
News|Articles|September 10, 2025
The Evolving Role of Mohs Surgeons in Advancing Management of laBCC
Advertisement
Episodes in this series

Now Playing
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus
2
Atopia Therapeutics Reports Positive Preclinical Data for ATP-R13 as Disease-Modifying Oral AD Therapy
3
LEVEL UP Study Shows Benefits of Switching From Dupilumab to Upadacitinib in AD
4
Case-Based Perspectives on Biologic Treatment for Hidradenitis Suppurativa
5
















